LINK:  https://bswhealth.webex.com/bswhealth/j.php?MTID=me47af01082245b1fd3d49a8843cd960a

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Describe pathophysiology, clinical features and indications for treatment for mitral valve disease, (2) Available therapeutic options - Percutaneous and Surgical (3) Emerging therapies and ongoing clinical trials.

FACULTY DISCLOSURE: Sukesh Burjonroppa, MD, is on the speakers’ bureau for Medtronic Device Company.

All relevant financial relationships have been mitigated.

PLANNER DISCLOSURE: Jay Herd, MD and Dipesh Bista, MD, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Mary Biggers at Mary.Biggers@BSWHealth.org